SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318771-05-000005
Filing Date
2005-05-02
Accepted
2005-05-02 17:17:15
Documents
7
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 GENENTECH, INC. - Q1 2005 FORM 10-Q (MARCH 31, 2005) dna-10q_0105.htm 10-Q 457111
2 FORM OF INDEMNIFICATION AGREEMENT FOR DIRECTORS AND OFFICERS dna-ex10_28.htm EX-10.28 35008
3 LETTER REGARDING UNAUDITED INTERIM FINANCIAL INFORMATION dna-ex15_1.htm EX-15.1 2031
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( dna-ex31_1.htm EX-31.1 5987
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( dna-ex31_2.htm EX-31.2 6327
6 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT T dna-ex32_1.htm EX-32.1 3832
7 "UNOFFICIAL" PDF COPY OF FORM 10-Q (MARCH 31, 2005) dna-10q_0105.pdf 10-Q 330125
  Complete submission text file 0000318771-05-000005.txt   966774
Mailing Address 1 DNA WAY . SOUTH SAN FRANCISCO CA 94080
Business Address 1 DNA WAY SOUTH SAN FRANCISCO CA 94080 650-225-1000
GENENTECH INC (Filer) CIK: 0000318771 (see all company filings)

IRS No.: 942347624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-09813 | Film No.: 05791783
SIC: 2834 Pharmaceutical Preparations